Automation bias happens when healthcare workers trust AI results too much, even if the system gives wrong or biased information. This causes them to accept AI advice without enough careful thinking, which can harm patient safety and care quality. Unlike regular mistakes, automation bias comes from relying too much on technology, which can make clinical judgment weaker over time.
The World Health Organization (WHO) has recently pointed out concerns about large multi-modal models (LMMs). These are advanced AI systems that can process text, pictures, and videos and give complex answers similar to human communication. These AI systems have been adopted faster than almost any other consumer technology. Platforms like ChatGPT, Bard, and similar AI tools started being used in U.S. healthcare by 2023.
In healthcare, LMMs and other AI tools do many jobs such as checking patient symptoms, diagnosing, handling clerical work, and doing research. But their strong support also comes with risks, including automation bias.
According to a 2025 American Medical Association (AMA) survey, 66% of U.S. doctors use AI in their work, up from 38% in 2023. While many see AI benefits, there are worries about relying on AI too much or using it wrongly. This shows managing automation bias is very important even as AI improves healthcare.
AI bias goes beyond just trusting AI too much. It also raises questions about fairness and patient safety. Research by experts like Matthew G. Hanna and others shows three types of biases that affect healthcare AI models:
In the U.S., where healthcare differences based on race, ethnicity, gender, and income still exist, biased AI models can make these gaps worse. For example, AI diagnostic tools may not work well for minority groups if their data is missing.
WHO advises that AI development should be open and involve healthcare providers, patients, and regulators early and often. This helps make sure AI meets ethical rules and clinical needs.
One important area to reduce automation bias is workflow automation in medical offices. Front-office tasks like appointment booking, answering patient calls, billing, and managing documents take a lot of time and effort. AI-driven automation can handle these tasks better, letting clinical staff spend more time caring for patients.
Simbo AI is a company that offers front-office phone automation and AI answering services. This shows how AI can improve healthcare workflows. By managing routine phone calls and patient messages, Simbo AI lowers the human workload in busy U.S. medical offices. This automation has some effects:
But workflow automation also connects with automation bias risks when AI tools lead directly to clinical decision systems. For example, if Simbo AI’s communications connect straight to clinical documents or symptom checks, staff might trust AI answers without checking properly.
So, it is important to combine workflow automation with clear rules and human review. In the U.S., HIPAA rules require privacy protection, making AI audit trails and data safety very important for these systems.
To lower automation bias risks when using AI in U.S. healthcare, some strategies should be followed:
Medical leaders and IT managers should run training programs that explain what AI can and cannot do, including the risks of automation bias. Clinicians should be taught to think critically about AI results instead of trusting them blindly.
Use AI tools that show how decisions are made. This helps clinical users understand why AI gives certain advice and catch possible mistakes or bias before acting.
Involve different experts—clinicians, IT staff, ethicists, and patients—at all stages of AI development to spot problems and ethical issues early. WHO supports broad engagement to create reliable, fair AI models.
Medical offices need clear rules about when and how clinicians should rely on AI, including required checks or second opinions for important decisions.
Keep checking AI performance regularly to find new bias or accuracy problems. WHO recommends mandatory checks after AI is released, focusing on effects on different groups. This matches U.S. rules that focus on patient safety.
Make it easy for clinicians to use AI by fitting it well with electronic health records and workflows. This reduces the chance clinicians will just accept AI because it is easier than checking manually.
Make sure training data includes many kinds of people. In the U.S., this means carefully choosing patient records that cover different races, ages, genders, and income levels to improve AI fairness.
Federal and state governments have an important job in reducing automation bias by setting rules for AI in clinical areas. The Food and Drug Administration (FDA) is updating standards for AI medical devices and decision tools to keep them safe and effective.
WHO asks governments to:
For U.S. medical leaders and IT managers, staying informed about changing rules is key when adopting AI tools.
Using advanced AI systems for clinical decisions is an important change in U.S. healthcare. AI can analyze data fast, make predictions, and help with administration to improve care and efficiency. But automation bias is a big problem if healthcare workers trust AI too much and lose careful clinical thinking.
To handle this, people need education, clear AI rules, proper regulation, good workflow integration, and constant oversight. Tools like Simbo AI’s front-office automation show that AI can help with healthcare tasks. Still, AI decisions and human expertise must be balanced carefully.
If automation bias is managed well, U.S. medical practices can get the best from AI while keeping patients safe and maintaining trust.
This plan shows how administrators, owners, and IT managers can deal with AI challenges in U.S. healthcare. With good planning and ongoing attention, healthcare AI can work well without reducing fairness or care quality.
LMMs are advanced generative artificial intelligence systems that process multiple types of data inputs, like text, images, and videos, generating varied outputs. Their capability to mimic human communication and perform unforeseen tasks makes them valuable in healthcare applications.
LMMs can be used in diagnosis and clinical care, patient-guided symptom investigation, clerical and administrative tasks within electronic health records, medical and nursing education with simulated encounters, and scientific research including drug development.
Risks include producing inaccurate, biased, or incomplete information, leading to harm in health decision-making. Biases may arise from poor quality or skewed training data related to race, gender, or age. Automation bias and cybersecurity vulnerabilities also threaten patient safety and trust.
WHO recommends transparency in design, development, and regulatory oversight; engagement of multiple stakeholders; government-led cooperative regulation; and mandatory impact assessments including ethics and data protection audits conducted by independent third parties.
Governments should set ethical and human rights standards, invest in accessible public AI infrastructure, establish or assign regulatory bodies for LMM approval, and mandate post-deployment audits to ensure safety, fairness, and transparency in healthcare AI use.
Engaging scientists, healthcare professionals, patients, and civil society from early stages ensures AI models address real-world ethical concerns, increase trust, improve task accuracy, and foster transparency, thereby aligning AI development with patient and system needs.
If only expensive or proprietary LMMs are accessible, this may worsen health inequities globally. WHO stresses the need for equitable access to high-performance LMM technologies to avoid creating disparities in healthcare outcomes.
LMMs should be programmed for well-defined, reliable tasks that enhance healthcare system capacity and patient outcomes, with developers predicting potential secondary effects to minimize unintended harms.
Automation bias leads professionals to overly rely on AI outputs, potentially overlooking errors or delegating complex decisions to LMMs inappropriately, which can compromise patient safety and clinical judgment.
WHO advises implementing laws and regulations to ensure LMMs respect dignity, autonomy, and privacy; enforcing ethical AI principles; and promoting continuous monitoring and auditing to uphold human rights and patient protection in healthcare AI applications.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
